1509919-85-0Relevant articles and documents
Crystal structures of PI3Kα complexed with PI103 and its derivatives: New directions for inhibitors design
Zhao, Yanlong,Zhang, Xi,Chen, Yingyi,Lu, Shaoyong,Peng, Yuefeng,Wang, Xiang,Guo, Chengliang,Zhou, Aiwu,Zhang, Jingmiao,Luo, Yu,Shen, Qiancheng,Ding, Jian,Meng, Linghua,Zhang, Jian
supporting information, p. 138 - 142 (2014/03/21)
The phosphatidylinositol 3-kinase (PI3K) signaling pathway plays important roles in cell proliferation, growth, and survival. Hyperactivated PI3K is frequently found in a wide variety of human cancers, validating it as a promising target for cancer therapy. We determined the crystal structure of the human PI3Kα-PI103 complex to unravel molecular interactions. Based on the structure, substitution at the R1 position of the phenol portion of PI103 was demonstrated to improve binding affinity via forming a new H-bond with Lys802 at the bottom of the ATP catalytic site. Interestingly, the crystal structure of the PI3Kα-9d complex revealed that the flexibility of Lys802 can also induce additional space at the catalytic site for further modification. Thus, these crystal structures provide a molecular basis for the strong and specific interactions and demonstrate the important role of Lys802 in the design of novel PI3Kα inhibitors.
